In March 2021, the company completed a 50 million investment led by Sunshine Ronghui Capital Round A Financing.

Completed a joint investment of 176 million yuan led by Boyuan Capital and Sherpa Investment, with co investment from Cornerstone Capital and Wuzhong Biomedical Industry Fund in December 2021 B-round Financing.

Complete a 190 million yuan investment led by Guoshou Equity Investment and co invested by CICC Capital in June 2023 C-round Financing.

Complete the participation of 70 million yuan by Gaoke Xinjun, Jianxin Equity, Shunbai Capital, and others in September 2023 C+wheel Financing.